ARTICLE | Clinical News
RT002: Phase II started
January 19, 2015 8:00 AM UTC
Revance began the double-blind, Canadian Phase II BELMONT trial to compare 3 dose levels of intramuscular RT002 vs. placebo and intramuscular Botox Cosmetic onabotulinumtoxinA in about 250 patients. ...